inclusion criteria: 1. men and women aged 18 and over at the time of signing the informed consent. 2. the patient is willing and able to give written informed consent to participate in the study and follow the procedures specified in the protocol. 3. diagnosed with covid-19, confirmed by a pcr test positive for the sars-cov-2 coronavirus in smears from the nasopharynx and oropharynx. 4. indications for hospitalization for covid-19 treatment: a moderate condition that does not require oxygen support or low oxygen flow required through a nasal cannula or oxygen mask. 5. a urine test performed during screening, negative for pregnancy in women capable of childbearing.

inclusion criteria: 1. men and women aged 18 and over at the time of signing the informed consent. 2. the patient is willing and able to give written informed consent to participate in the study and follow the procedures specified in the protocol. 3. diagnosed with covid-19, confirmed by a pcr test positive for the sars-cov-2 coronavirus in smears from the nasopharynx and oropharynx. 4. indications for hospitalization for covid-19 treatment: a moderate condition that does not require oxygen support or low oxygen flow required through a nasal cannula or oxygen mask. 5. a urine test performed during screening, negative for pregnancy in women capable of childbearing.

inclusion criteria: men and women aged 18 and over at the time of signing the informed consent. the patient is willing and able to give written informed consent to participate in the study and follow the procedures specified in the protocol. diagnosed with covid-19, confirmed by a pcr test positive for the sars-cov-2 coronavirus in smears from the nasopharynx and oropharynx. indications for hospitalization for covid-19 treatment: a moderate condition that does not require oxygen support or low oxygen flow required through a nasal cannula or oxygen mask. a urine test performed during screening, negative for pregnancy in women capable of childbearing.

inclusion criteria: men and women aged 18 and over at the time of signing the informed consent. the patient is willing and able to give written informed consent to participate in the study and follow the procedures specified in the protocol. diagnosed with covid-19, confirmed by a pcr test positive for the sars-cov-2 coronavirus in smears from the nasopharynx and oropharynx. indications for hospitalization for covid-19 treatment: a moderate condition that does not require oxygen support or low oxygen flow required through a nasal cannula or oxygen mask. a urine test performed during screening, negative for pregnancy in women capable of childbearing.

inclusion criteria: 1. men and women aged 18 and over at the time of signing the informed consent. 2. the patient is willing and able to give written informed consent to participate in the study and follow the procedures specified in the protocol. 3. diagnosed with covid-19, confirmed by a pcr test positive for the sars-cov-2 coronavirus in smears from the nasopharynx and oropharynx. 4. indications for hospitalization for covid-19 treatment: a moderate condition that does not require oxygen support or low oxygen flow required through a nasal cannula or oxygen mask. 5. a urine test performed during screening, negative for pregnancy in women capable of childbearing.

inclusion criteria: 1. men and women aged 18 and over at the time of signing the informed consent. 2. the patient is willing and able to give written informed consent to participate in the study and follow the procedures specified in the protocol. 3. diagnosed with covid-19, confirmed by a pcr test positive for the sars-cov-2 coronavirus in smears from the nasopharynx and oropharynx. 4. indications for hospitalization for covid-19 treatment: a moderate condition that does not require oxygen support or low oxygen flow required through a nasal cannula or oxygen mask. 5. a urine test performed during screening, negative for pregnancy in women capable of childbearing.